In this week’s DeviceTalks Weekly podcast, co-costs Tom Salemi and Chris Newmarker walk through this week’s “Newmarker’s Newsmakers,” the Top Five #medtech stories of the week with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer. We also hear from CEO Harith Rajagopalan, MD and CFO Lisa Davidson of Fractyl Laboratories, which is […]
Cala cites positive data in Trio tremor trial
Bioelectronic company Cala Health released positive data from its ongoing PROSPECT trial demonstrating that a majority of patients using its FDA-cleared Cala Trio device reported a reduction in hand tremors. The study — published in Tremor and Other Hyperkinetic Movements — enrolled 263 patients with essential tremor across 26 sites. Patients wore the Trio on […]
FDA gives additional OK to point-of-care MRI
Hyperfine Research Inc. will begin rolling out a commercial launch for its Swoop Portable MR imaging device after receiving an additional 510(k) approval from the FDA, which will permit the system to be used on newborns and infants. In a release, the Guilford, Conn.-based company defines Swoop as a “point-of-care MR imaging device that wheels […]
DTW Podcast: Vizient on PPE, Vicarious on VR-aided robotics and let’s all hope for pumpernickel
This week’s episode of DeviceTalks Weekly is brought to you by the later V, as in Vizient and Vicarious Surgical. Bharat Sundaram, COO and president of Vizient, will share how the healthcare supplier is strengthening the supply of PPE for hospitals. He’ll also reveal when the company expects to see US hospitals running at pre-COVID […]
This telemedicine system could get medtech sales reps back to ORs
Daniel Hawkins’ surprise isn’t a matter of what, but when. The successful medtech executive and former Shockwave Medical CEO fully expected medical device makers would see Avail Medsystem’s telemedicine system as a more efficient way for sales reps to sit in on surgeries. By Hawkins’ projections, Avail’s system would eliminate much of the time sales […]
Bodyport secures $11.2m to build ‘virtual cardiac clinic’ for your bathroom
Bodyport, a company building sensitive sensor technologies into a bathroom scale, secured an $11.2 million Series A round to develop a device that can help detect and manage heart disease by detecting cardiac signals and biomarkers through bare feet. Boehringer Ingelheim Venture Fund (BIVF) led the round in the San Francisco-based startup, adding its capital […]
Medtech and COVID-19: 7 things you need to know
When COVID-19 set upon the U.S. in March, medtech executives only had a month at most to explain to analysts in quarterly calls how the pandemic was hitting their companies — not nearly enough time to understand the long-term impact. Three more months have passed since those quarterly calls, and we’re now wrapping up a […]
Fractyl adds $55M Series E for Type 2 diabetes pivotal trial
Fractyl Laboratories secured $55 million for a Series E financing to continue funding a pivotal clinical trial of its potential non-drug, non-surgical treatment for Type 2 diabetes, according to the company. The capital will go toward the Lexington, Mass-based start up’s Revita T2Di pivotal clinical trial of Revita DMR (duodenal mucosal resurfacing). Revita is measuring […]
DTW Podcast: 10 ways medtech is finding its footing amid COVID-19
When COVID-19 set upon the U.S. in March, medtech executives had a month at most to tell Wall Street analysts how the pandemic had hit the industry’s largest companies. We heard about short-term hits in revenues, procedures and employee headcounts, but uncertainty clearly ruled the day. Over the past few weeks, medtech executives from several […]
DTW: What in the world will Thrive Earlier Detection do with $257 million?
In this week’s podcast, two executives from Thrive Earlier Detection explain how the “turbo-charged” diagnostics company intends to upend how, when and where cancer is diagnosed. Dr. Isaac Kinde, co-founder and head of research and innovation, walks us through the company’s CancerSEEK test and how the company is marrying new technology with an innovative clinical […]
Thrive raises $257m for CancerSeek
Investors once again lined up behind Thrive Earlier Detection and its potentially revolutionary cancer diagnostic The one-year-old start raised a $257 million Series B round from a syndicate of venture and crossover investors, including round leaders Casdin Capital and Section 32 and new investors Bain Capital Life Sciences, Brown Advisory, Driehaus Capital Management, Intermountain Ventures, […]